http://photos.prnewswire.com/prnh/20130307/600769
POC testing based on microfluidic technology is expected to grow sharply, from $1.6B in 2013 to $5.6B in 2019, at a CAGR 2014 - 2019 of 23%. Major diagnostics companies (Alere, Abbott Point of Care, BD Diagnostics, Cepheid, Abaxis, etc.) have realized the potential of rapid molecular diagnostic testing.
Based on a complete analysis of the last three years' developments, we have been able to draw effective conclusions. Despite slower than expected growth in 2012, we explain why strong future growth is still likely.
POC 2014 report describes the following applications:
Each of these are explained using market data, trends and drivers, key players and technologies used.
Also, growth perspectives and a value chain analysis are detailed for each application, and examples of innovative products are provided.
Moreover, this new report provides an overview of nearly 65 new technologies (commercialized or close to market), with information regarding commercial status, targeted application, technology description, sample volume, sensitivity level and target price
Key Topics Covered:
Executive summary
Introduction
The market for Point of Care diagnostics
What's happened since 2011?
Market segmentation
Point of Care technologies
Success stories analysis
POC challenges
Supply and value chain
Outlook
Summary and conclusions
Companies Mentioned:3M Abaxis Abbott Point of Care Accumetrics Achira Akonni Biosystems Alere Ativa Bio-Rad BioCartis Biodetection Instruments Cepheid Curetis DNA Electronics Daktari Enigma Diagnostics F-Cubed Focus Diagnostic GenePOC Genefluidics Great Basin Handylab (BD) IBM INO Ikerlan Iquum Johnson & Johnson (Amic) LeukoDX Lumora MIT Lincoln Laboratory Medimate Molbio Diagnostics Molecular Vision (Abingdon Health) Nanosphere NetBio Norchip OPKO Diagnostics OcuSense On-Chip Biotechnologies Pall Corporation Philips Rheonix Roche STMicroelectronics Siemens Smiths Detection Sony (Micronics) SpinChip Diagnostics AS ThermoFisher Vista Therapeutics Wako Diagnostics Zyomyx Inc bioMérieuxFor more information visit http://www.researchandmarkets.com/research/x2l8qm/point_of_care
Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net
SOURCE Research and Markets
RELATED LINKS
http://www.researchandmarkets.com
A UBM plc company.
Powered by Clickability.
$('#mobile-login').on('click', function () { $('#mobile-login').popover('show')})$('#mobile-share').on('click', function () { $('#mobile-share').popover('show')})$('#mobile-search').on('click', function () { $('#mobile-search').popover('show')})$('[rel=popover]').popover({ html:true, placement:'bottom', content:function(){ return $($(this).data('contentwrapper')).html(); }});audiojs.events.ready(function() { var as = audiojs.createAll();});var clickedCarousel;var clickedSlide;var windowWidth;var carouselContent = $('.prn-carousel-modal').html();$('.photo').hammer().on('tap', function(event){ event.preventDefault(); windowWidth = $(window).width(); clickedSlide = $(event.target).parents('.slide').prevAll().length; if ( windowWidth > 480 ) { clickedCarousel = $(event.target).parents('.photo').prevAll().length + clickedSlide * 3; } else { clickedCarousel = clickedSlide; }}); // Flexslider $('#flexslider-modal').on('shown.bs.modal', function () {$('#slider').flexslider({ animation: "slide", controlNav: false, animationLoop: false, video: true, slideshow: false, touch: true, itemMargin: 45, sync: "#carousel", smoothHeight: true, useCSS: true }); $('#carousel').flexslider({ animation: "slide", controlNav: false, directionNav: true, animationLoop: false, slideshow: false, itemWidth: 150, itemMargin: 5, useCSS: false, //thins type if true asNavFor: '#slider' }); var carouselItem = $('#carousel li').eq(clickedCarousel); var carouselItemHeight = carouselItem.outerHeight(); carouselItem.trigger('click'); $('#slider .flex-viewport').delay(2000).stop(true, true).innerHeight(carouselItemHeight); }).on('hidden.bs.modal', function () { $('.prn-carousel-modal .modal-dialog').remove(); $('.prn-carousel-modal').html(carouselContent); });
No comments:
Post a Comment